糖尿病患者共患高尿酸现状及影响因素调查

doi:10.12183/j.scjpm.2024.0455

[1] 国家卫生健康委.中国居民营养与慢性病状况报告(2020年)[J]. 营养学报,2020,42(6):521.
[2] 杜丹阳,李素丽,热孜万古丽·乌斯曼,等.新疆地区年轻的成年发病型糖尿病基因筛查研究[J]. 中国糖尿病杂志,2022,30(3):174-179.
[3] 中华医学会糖尿病学分会,国家基层糖尿病防治管理办公室.国家基层糖尿病防治管理指南(2022)[J].中华内科杂志,2022,61(3):249-262.
[4] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409.
[5] 熊圣喜,张然然,胡红艳,等. 2型糖尿病患者葡萄糖目标范围内时间与高尿酸血症的相关性研究[J]. 中华内分泌代谢杂志,2023,39(7):565-570.
[6] 王迪,王希,尹福在,等. 中国人内脏脂肪指数与2型糖尿病合并高尿酸血症的相关性研究[J]. 河北医药,2022,44(11):1699-1701,1705.
[7] 陈柔柔,李娜,赫荣波,等.新诊断2型糖尿病合并高尿酸血症患者的临床特征及肠道菌群变化[J].南京医科大学学报(自然科学版),2022,42(8):1125-1132,1141.
[8] 范美娟,邓美玉,徐会,等. 2型糖尿病患者高尿酸血症流行状况与相关因素研究[J]. 中国糖尿病杂志,2018,26(12):1013-1016.
[9] 黄花,徐冬冬,任建宇. 2型糖尿病合并高尿酸血症青年患者代谢相关因素分析[J]. 中国现代医学杂志,2020,30(21):53-57.
[10] 北京市疾病预防控制中心.2014年北京市成人慢性病及危险因素监测报告[M].北京:中国文史出版社,2014:44-78.
[11] 中华人民共和国卫生部疾病预防控制局.中国成人身体活动指南(试行)[M].北京:人民卫生出版社,2011:4-10.
[12] 中国成人血脂异常防治指南制定联合委员会.中国成人血脂异常防治指南(2016年修订版)[J].中华全科医师杂志,2017,16(1):15-35.
[13] 杨青,刘雪琴.中文版糖尿病痛苦量表信效度评价[J].护理学报,2010,17(17):8-10.
[14] 高尿酸血症相关疾病诊疗多学科共识专家组.中国高尿酸血症相关疾病诊疗多学科专家共识[J]. 中华内科杂志,2017,56(3):235-248.
[15] Ramos GK,Goldfarb DS.Update on uric acid and the kidney[J].Curr Rheumatol Rep,2022,24(5):132-138.
[16] Fralick M,Chen SK,Patorno E,et al.Assessing the risk for gout with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes:A population-based cohort study[J].Ann Intern Med,2020,172(3):186-194.
[17] 周利敏,肖丽勇,李艳玲.郑州市2型糖尿病患者高尿酸血症流行状况与相关因素研究[J].华南预防医学,2022,48(1):61-63,67.
[18] 陈亨贵, 盛丽婷,万真真,等.中国居民吸烟与高尿酸血症的相关性分析[J].中华预防医学杂志,2018,52(5):524-529.

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 0

[1]	WANG Ling, YU Juxiang, WU Hui, ZHANG Hong, LI Yi, LIU Yi, JIANG Jianlan, MENG Jiajun. Analysis of the status and indication changes for cesarean section in Huainan region,2019-2022 [J]. South China Journal of Preventive Medicine, 2024, 50(5): 400-404.
[2]	. [J]. South China Journal of Preventive Medicine, 2024, 50(5): 424-428.
[3]	. [J]. South China Journal of Preventive Medicine, 2024, 50(5): 429-432.
[4]	. [J]. South China Journal of Preventive Medicine, 2024, 50(5): 437-440.
[5]	. [J]. South China Journal of Preventive Medicine, 2024, 50(5): 441-444.
[6]	XIE Wei, ZHAO Zhiguang, WU Xiaobing, XIE Fengzhu, SHANG Qinggang, WU Xiaoyan, LYU Deliang. Prevalence and influencing factors of dyslipidemia in adults in Shenzhen [J]. South China Journal of Preventive Medicine, 2024, 50(4): 314-318.
[7]	. [J]. South China Journal of Preventive Medicine, 2024, 50(4): 337-339.
[8]	. [J]. South China Journal of Preventive Medicine, 2024, 50(4): 352-356.
[9]	. [J]. South China Journal of Preventive Medicine, 2024, 50(4): 357-360.
[10]	. [J]. South China Journal of Preventive Medicine, 2024, 50(4): 361-363.
[11]	. [J]. South China Journal of Preventive Medicine, 2024, 50(4): 364-367.
[12]	ZHANG Qing, ZHANG Weisen, JIANG Zhaoqiang, JIN Yali, XU Lin. Correlation of obesity and physical activity with serum liver function indicators in middle-aged and elderly population in Guangzhou [J]. South China Journal of Preventive Medicine, 2024, 50(3): 199-204.
[13]	LI Rui, LI Li, WEI Jia, ZHAO Lingjun, ZENG Qinya, WANG Jinli, LEI Jie. Analysis of delayed recovery after general anesthesia and its influencing factors [J]. South China Journal of Preventive Medicine, 2024, 50(3): 222-226.
[14]	ZHANG Lan, GUO Yanqiang. Effects of overweight/obesity and dyslipidemia and their interactions on blood pressure control in community hypertensive patients [J]. South China Journal of Preventive Medicine, 2024, 50(3): 227-230.
[15]	JIANG Ruilian, DAI Juan. Characteristics of cardiovascular and cerebrovascular events in Wuhan,2014 - 2020 [J]. South China Journal of Preventive Medicine, 2024, 50(3): 231-235.